Novarits
FDA wants more information on Novartis arthritis drug
August 31, 2011Sales and Marketing FDA, Ilaris, Novarits, canakinumab
The FDA has asked Novartis for more information on its gouty arthritis drug canakinumab. The regulator’s request came in a …
Phase III drug superior to Spiriva, says Novartis
May 21, 2009Research and Development, Sales and Marketing COPD, Novarits
Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
